Academic Myocardial Infarction Thrombolysis 
Circulation: Cardiovascular Interventions
JANUARY 23, 2024
BACKGROUND:It is uncertain whether adjunctive thrombolysis is beneficial for patients with ST-segment–elevation myocardial infarction undergoing percutaneous coronary intervention (PCI) within 120 minutes of presentation. The infarct size was detected by cardiac magnetic resonance 5 days after randomization. versus 29.0%;P<0.001)
Dr. S. Venkatesan MD
SEPTEMBER 1, 2024
CAPTIM trial was published in 2002, which left a gospel truth in the science of myocardial reperfusion (two decades gone now). It is a sad academic story ,most of the interventional cardiology community shrugged it off as a non-event. In this context, we need a movement to revive the pre-hospital thrombolysis.
Dr. Anish Koka
JANUARY 18, 2023
The open-data movement seeks to liberate the massive amount of data generated in running clinical trials from the grasp of the academic medical-pharmaceutical industrial complex that mostly runs the most important trials responsible for bringing novel therapeutics to market. But first, some background.
Dr. Smith's ECG Blog
MARCH 14, 2025
ECG #3 is easily recognized as OMI and the AI model recommends immediate revascularization The patient in today's case received suboptimal care and suffered a substantial myocardial infarction. Here is evidence for this: Opiates are associated with worse outcomes in Myocardial Infarction. Abstract 556.
Dr. Smith's ECG Blog
APRIL 9, 2025
REFERENCE Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine [link] Primary ventricular fibrillation (VF) during an acute myocardial infarction (AMI) occurs with a high incidence and mortality rate with or without thrombolysis. Mortality rates were 10.5%
Expert insights. Personalized for you.
40 
Let's personalize your content